Caspofungin acetate
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
- Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
- Note: not well studied in endocarditis, osteomyelitis, and meningitis (low CNS penetration) due to Candida.
- Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
- Empiric treatment of presumed fungal infections in febrile neutropenic patients.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
- Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections.
- Note: not well studied in endocarditis, osteomyelitis, and meningitis (low CNS penetration) due to Candida.
- Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
- Empiric treatment of presumed fungal infections in febrile neutropenic patients.
There's more to see -- the rest of this entry is available only to subscribers.